Status:
NOT_YET_RECRUITING
Differentiated Thyroid Cancer Patients Treated With Different Doses of Radioactive Iodine.
Lead Sponsor:
Assiut University
Conditions:
Thyroid Cancer
Eligibility:
All Genders
Brief Summary
1. Determine the frequency of utilizing single and multiple doses of radioactive iodine (RAI) in treatment of differentiated thyroid cancer. 2. Asses the impact of various doses of radioactive iodine ...
Detailed Description
Differentiated thyroid cancer represents more than 90% of cancer thyroid \[1\]. Total thyroidectomy is considered the mainstay of curative therapy, with radioactive iodine (RAI) in order to ablate or ...
Eligibility Criteria
Inclusion
- • Patients with differentiated cancer thyroid either papillary or follicular underwent total thyroidectomy with or without lymph node dissection.
- Available data of patients' records.
Exclusion
- • Missed follow up data.
Key Trial Info
Start Date :
March 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06134830
Start Date
March 1 2024
End Date
January 1 2027
Last Update
February 6 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.